Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Insight Acquires Monistat In Third Deal With McNeil For Women’s OTC Drugs

This article was originally published in The Tan Sheet

Executive Summary

Insight Pharmaceutical expanded its women’s health care footprint with the acquisition of the Monistat North American portfolio from McNeil Consumer Healthcare.
Advertisement

Related Content

J&J’s Mylanta, Mylicon Lines Return Via ‘Fixed-Term’ License With Infirst
J&J’s Mylanta, Mylicon Lines Return Via ‘Fixed-Term’ License With Infirst
In Brief: Prestige Buys Insight, Quarterly Earnings For MJN And Colgate, Bio-Recovery Warned On Claims
J&J Brand Revival Plan Relies On Marketing, Delivery Innovation
J&J Consumer Recaptures Growth, Plans To Restore Most OTCs By Mid-2012
Top Pharmacist-Recommended OTCs
GlaxoSmithKline's OTC Garage Sale Includes alli, FiberChoice
J&J/McNeil Divests E.P.T. Pregnancy Tests To Insight Pharmaceuticals
J&J/McNeil Divests E.P.T. Pregnancy Tests To Insight Pharmaceuticals
J&J Washes Hands Of Purell As GOJO Eyes Consumer Segment Growth

Topics

Advertisement
UsernamePublicRestriction

Register

PS105275

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel